PRQRProQR Therapeutics N.V.
2.340USDMkt Cap: 330.22M $P/E: —3d ago
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing techn…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap330.22M $
Enterprise Value147.79M $
Revenue (TTM)18.42M $
Gross Profit18.42M $
Net Income (TTM)-42.18M $
Revenue/Share0.1730 USD
Last Price2.340 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees186
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.08
PEG—
EV/EBITDA-3.53
EV/Revenue8.02
P/S17.39
P/B5.50
EPS (TTM)-0.46
EPS (Forward)-0.56
52W Range
2.26073% of range2.370
52W High2.370 USD
52W Low2.260 USD
Profitability
Gross Margin100.00%
Oper. Margin-100.72%
EBITDA Margin-227.44%
Profit Margin-265.21%
ROE-85.44%
ROA-37.41%
Growth
Revenue Growth120.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-52.79M $
CapEx (TTM)1.02M $
FCF Margin-103.53%
FCF Yield-5.78%
Net Debt-101.81M $
Net Debt/EBITDA2.43
Balance Sheet
Debt/Equity0.32
Current Ratio3.49
Quick Ratio3.49
Book Value/Sh0.4126 USD
Cash/Share1.065 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.222 USD
Upside (mean)+251.4%
Target Range3.000 USD – 12.00 USD
$3.000+251.4% to mean$12.00
# Analysts9
Ownership
Shares Out.141.12M
Float71.25M
Insiders17.16%
Institutions54.54%
Short Interest
Short Ratio2.1d
Short % Float2.07%
Short % Out.1.57%
Shares Short2.22M
Short (prev mo.)1.20M
Technical
SMA 501.761 (+32.9%)
SMA 2001.788 (+30.9%)
Beta0.03
S&P 52W Chg21.00%
Avg Vol (30d)720.15K
Avg Vol (10d)757.28K
Technical Indicators
RSI (14)73.4
MACD0.1260
MACD Signal0.0782
MACD Hist.+0.0478
BB Upper2.291 USD
BB Middle1.914 USD
BB Lower1.536 USD
BB Width39.43%
ATR (14)0.1379 USD
Vol Ratio (20d)0.85x